Blog

Using a new technique for imaging embryos in real time, a team led by scientists at the Loke Centre for Trophoblast Research, University of Cambridge, showed that abnormalities can arise at a later stage of embryo development than previously…

A new analysis of the landmark SELECT trial, published in The Lancet, confirms that semaglutide reduces the risk of major cardiovascular events in people with obesity and preexisting heart disease — even in those without diabetes and…

There certainly are potential downsides. As a 2021 review of fever in the Covid-19 pandemic era put it: “blocking fever can be harmful because fever, along with other sickness symptoms, evolved as a defence against infection”.   

Using…